Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
Cytotec 200 microgram tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White to off-white hexagonal tablets scored both sides, engraved SEARLE 1461 on one side for oral administration. |
Each tablet contains 200 micrograms misoprostol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Misoprostol |
Misoprostol is an analogue of naturally occurring prostaglandin E1 which promotes peptic ulcer healing and symptomatic relief. Misoprostol protects the gastroduodenal mucosa by inhibiting basal, stimulated and nocturnal acid secretion and by reducing the volume of gastric secretions, the proteolytic activity of the gastric fluid, and increasing bicarbonate and mucus secretion. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
Cold-formed aluminium blister packs of 56, 60, 112, 120 or 140 tablets.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/0956
Date of first authorisation: 10 May 2002
Date of latest renewal: 24 June 2013
| Drug | Countries | |
|---|---|---|
| CYTOTEC | Ecuador, Estonia, Spain, Finland, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
